CAFFEIN

Cancer Associated Fibroblasts (CAF) Function in Tumor Expansion and Invasion

 Coordinatore KOBENHAVNS UNIVERSITET 

 Organization address postcode: 1017

contact info
Titolo: Ms.
Nome: Tine
Cognome: Mathiesen
Email: send email
Telefono: +45 35326346

 Nazionalità Coordinatore Denmark [DK]
 Totale costo 3˙312˙522 €
 EC contributo 3˙312˙522 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2012-ITN
 Funding Scheme MC-ITN
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-10-01   -   2016-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1 KOBENHAVNS UNIVERSITET DK coordinator 612˙571.60
2    MEDIMMUNE LIMITED*

 Organization address address: The Milstein Building Granta Park
city: Cambridge
postcode: CB1 6GH

contact info
Titolo: Mr.
Nome: Bruno
Cognome: Calo Fernández
Email: send email
Telefono: +44 1223 898 585

UK (Cambridge) participant 497˙460.47
3    WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER

 Organization address address: SCHLOSSPLATZ 2
city: MUENSTER
postcode: 48149

contact info
Titolo: Mr.
Nome: Ingo
Cognome: Niendorf
Email: send email
Telefono: +49 251 8355881
Fax: +49 251 8354035

DE (MUENSTER) participant 450˙737.75
4    UNIVERSITETET I BERGEN

 Organization address address: Museplassen 1
city: BERGEN
postcode: 5007

contact info
Titolo: Mrs.
Nome: Liv-Grethe
Cognome: Gudmundsen
Email: send email
Telefono: 4755584965

NO (BERGEN) participant 282˙471.40
5    OULUN YLIOPISTO

 Organization address address: Pentti Kaiteran Katu 1
city: OULU
postcode: 90014

contact info
Titolo: Mr.
Nome: Arto
Cognome: Eljander
Email: send email
Telefono: 358294000000
Fax: 35885534170

FI (OULU) participant 264˙497.62
6    TURUN YLIOPISTO

 Organization address address: YLIOPISTONMAKI
city: TURUN YLIOPISTO
postcode: 20014

contact info
Titolo: Dr.
Nome: Mari
Cognome: Riipinen
Email: send email
Telefono: +358 2 333 6054
Fax: +358 2 333 6446

FI (TURUN YLIOPISTO) participant 264˙497.62
7    KAROLINSKA INSTITUTET

 Organization address address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177

contact info
Titolo: Mrs.
Nome: Maria
Cognome: Von Witting
Email: send email
Telefono: +46 8 51775878

SE (STOCKHOLM) participant 263˙225.16
8    UNIVERSITE DE LIEGE

 Organization address city: LIEGE
postcode: 4000

contact info
Titolo: Dr.
Nome: Isabelle
Cognome: Halleux
Email: send email
Telefono: 3243665428
Fax: 3243662936

BE (LIEGE) participant 233˙640.00
9    UNIVERSITEIT GENT

 Organization address address: SINT PIETERSNIEUWSTRAAT 25
city: GENT
postcode: 9000

contact info
Titolo: Ms.
Nome: Nathalie
Cognome: Vandepitte
Email: send email
Telefono: 3292643029
Fax: 3292643583

BE (GENT) participant 233˙640.00
10    CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO

 Organization address address: UNIVERSIDADE DE COIMBRA .
city: COIMBRA
postcode: 3004 517

contact info
Titolo: Ms.
Nome: Silvia
Cognome: Sousa
Email: send email
Telefono: +351 239 853406

PT (COIMBRA) participant 209˙781.00
11    JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN

 Organization address address: GRUNEBURGPLATZ 1
city: FRANKFURT AM MAIN
postcode: 60323

contact info
Titolo: Ms.
Nome: Mareike
Cognome: Schmitt
Email: send email
Telefono: +49 69 79825194
Fax: +49 69 798 25194

DE (FRANKFURT AM MAIN) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

caf    company    medimmune    tumor    complementary    industry    gimmune    network    training    scientific    skills    esrs    industrial    excellent    area    cancer    ers    caffein    pharmaceutical   

 Obiettivo del progetto (Objective)

'Aim of the CAFFEIN network is to provide 10 early stage researchers (ESRs) and 2 exprerienced researchers (ERs) with excellent training in an industry relevant area of cancer research, complementary skills required for pharmaceutical industry, and knowledge in setting up biomedical start-up companies. To this end, the network comprises two full industrial partners: the established pharmaceutical company Medimmune, a global leader in immunopharmaceuticals, and the small biotech company Gimmune, which used breakthrough results in nanotechnology to establish a new enterprise. The research focus of CAFFEIN, which stands for Cancer Associated Fibroblasts (CAF) Function in Tumor Expansion and Invasion, is to understand the mechanisms, how fibroblastoid cells support tumor progression and metastasis formation. CAF biology is therefore rather complex, but the research groups of the CAFFEIN network cover many different aspects of it, thus having a critical mass to provide relevant training in this area. Training in complementary skills important for work in the pharmaceutical industry is provided by the industrial partner MedImmune, where communication with management, industrial project planning, IPR, etc. will be taught. Entrepreneurial skills, business plans, funding by venture capitalists, and patentability of research findings are highlights of the training provided by the industrial partner Gimmune. All this training is transmitted to the ESRs/ERs by networkwide events, secondments and tight research collaboration. Taken together, the CAFFEIN research training network combines the acquisition of excellent scientific knowledge in an area highly attractive for pharmaceutical industry with special education in relevant complementary skills that increase employment chances of the trained researchers in industry and that encourage them to translate their scientific results into products, thus improving health and economic welfare of European citizens.'

Altri progetti dello stesso programma (FP7-PEOPLE)

PHAGE-BEADS (2010)

Hydrogel-Phage Composite Materials and Droplet Microfluidics

Read More  

AGEWELL (2014)

"Ageing Migrants' Well-being: The Structuring of Local Welfare Provisions at the Intersection of Public, Private, Third Sector and the Family"

Read More  

ENCODING EXPERIENCE (2014)

Encodoing Social Interaction

Read More